Pathology News
editor

About Editor

This author has not yet filled in any details.
So far Editor has created 845 blog entries.

February 2026

Lumea’s IMS Viewer+™ Achieves CE Marking Under IVDR, Expanding Clinical Use Across Europe

2026-02-25T13:50:22+00:00

Lumea’s Viewer+™ software is now CE marked under IVDR for clinical use across Europe, making Lumea the most versatile browser-based diagnostic hub for the global market. Precision in medicine is a necessity. Pathology data informs nearly 70% of medical decisions, yet diagnostic quality is often hindered (or compromised) by a combination of inconsistencies in tissue handling and siloed [...]

Lumea’s IMS Viewer+™ Achieves CE Marking Under IVDR, Expanding Clinical Use Across Europe2026-02-25T13:50:22+00:00

Pathology Education: The Digital Future Is Here

2026-02-25T10:53:42+00:00

The next generations of pathologists are demanding digital education now As medicine becomes more precise and data-driven, pathology is undergoing a transformative shift toward digital technology. This transition promises to revolutionize how pathologists work, improving accuracy, efficiency, and collaboration, while ultimately enhancing patient outcomes. Nowhere is this transformation happening faster or more profoundly than in [...]

Pathology Education: The Digital Future Is Here2026-02-25T10:53:42+00:00

Lumito and Atlas Antibodies Enter Strategic Partnership to Advance High-resolution Tissue Imaging

2026-02-25T10:11:11+00:00

Lumito and Atlas Antibodies AB (“Atlas Antibodies”) today announce a strategic partnership aimed at accelerating innovation in tissue analysis and strengthening their respective positions in a growing global market. By combining Lumito’s proprietary high-sensitivity imaging technology with Atlas Antibodies’ extensively validated antibody portfolio, the collaboration is designed to create differentiated, value-driven solutions for research, translational applications, [...]

Lumito and Atlas Antibodies Enter Strategic Partnership to Advance High-resolution Tissue Imaging2026-02-25T10:11:11+00:00

Labcorp Expands Collaboration with PathAI to Deploy FDA-Cleared Digital Pathology Platform Nationwide

2026-02-25T10:05:40+00:00

AISight® Dx will support fully digital workflows and AI-enabled insights across Labcorp's network of anatomic pathology labs and hospital collaborations to improve efficiency, collaboration and patient care Labcorp, a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration with PathAI to deploy AISight® Dx1, an FDA-cleared digital pathology platform, across its [...]

Labcorp Expands Collaboration with PathAI to Deploy FDA-Cleared Digital Pathology Platform Nationwide2026-02-25T10:05:40+00:00

AI-Powered Proteogenomics Identifies Mitochondrial Signatures as Predictors of Melanoma Recurrence and Therapy Response

2026-02-23T10:00:25+00:00

by Christos Evangelou, MSc, PhD – Medical Writer and Editor  The Melanoma MEGA-Study, a decade-long study encompassing 1,653 patients from Hungary, integrated proteogenomics, AI-driven digital pathology, and clinical data to improve risk stratification for patients with melanoma. In an interview with Pathology News, Jeovanis Gil, PhD, one of the lead investigators of the Melanoma MEGA-Study, [...]

AI-Powered Proteogenomics Identifies Mitochondrial Signatures as Predictors of Melanoma Recurrence and Therapy Response2026-02-23T10:00:25+00:00

Taking AIM at Histologic Scoring Variability in Ulcerative Colitis

2026-02-24T13:28:54+00:00

Inflammatory bowel diseases, including ulcerative colitis (UC), are chronic gastrointestinal conditions that profoundly impact patients’ quality of life. Recently, treatment goals for patients with UC have shifted away from symptom control towards true healing of the colonic epithelium, with histologic remission emerging as a key metric of disease activity.1 Factors pathologists consider when examining UC biopsies [...]

Taking AIM at Histologic Scoring Variability in Ulcerative Colitis2026-02-24T13:28:54+00:00

HALO AP® is Now Rated in Best in KLAS®: Earning ‘A’ Grades in All Categories

2026-02-24T14:21:55+00:00

Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced recognition by KLAS for customer-rated performance in the European digital pathology market, earning 94.9/100* and an ‘A’ grade* in each category. Best in KLAS® honors software organizations that excel at helping healthcare professionals deliver better patient care, based on a meticulous, independent analysis [...]

HALO AP® is Now Rated in Best in KLAS®: Earning ‘A’ Grades in All Categories2026-02-24T14:21:55+00:00

Tempus AI, Inc.: A Bull Case Theory

2026-02-24T12:10:21+00:00

We came across a bullish thesis on Tempus AI, Inc. on R. Dennis’s Substack by OppCost. In this article, we will summarize the bulls’ thesis on TEM. Tempus AI, Inc.'s share was trading at $64.57 as of January 28th. TEM’s trailing P/E was 41.53 according to Yahoo Finance. Tempus AI, Inc. (NASDAQ: TEM) operates at the forefront of precision [...]

Tempus AI, Inc.: A Bull Case Theory2026-02-24T12:10:21+00:00

AI-Enhanced Optical Coherence Photoacoustic Microscopy Revolutionizes 3D Cancer Model Imaging

2026-02-26T10:54:13+00:00

In the relentless pursuit of breakthroughs in cancer research and therapeutic development, three-dimensional cancer models such as organoids and spheroids have emerged as indispensable tools. These biomimetic constructs faithfully recapitulate the complex heterogeneity and intricate pathophysiology of tumors, all within a controlled in vitro environment. Despite their transformative potential, the technical challenge of non-invasively visualizing these 3D [...]

AI-Enhanced Optical Coherence Photoacoustic Microscopy Revolutionizes 3D Cancer Model Imaging2026-02-26T10:54:13+00:00

ASCO President Elect Talks Advancing Patient-Centered Care and Team-Based Innovation

2026-02-26T09:06:51+00:00

Author: Ariana Pelosci Fact checked by: Roman Fabbricatore Deb Schrag, MD, MPH, discusses her journey into GI oncology, the development of patient-reported outcome systems, and her vision for the upcoming ASCO presidency. Oncology has transitioned from a generalist field to one of immense sub-specialization, expanding to nearly 1000 different therapeutic options. For Deb Schrag, [...]

ASCO President Elect Talks Advancing Patient-Centered Care and Team-Based Innovation2026-02-26T09:06:51+00:00
Go to Top